Chalazion Treatment: A Concise Review of Clinical Trials

A chalazion is one of the most common eye conditions presenting as a mass lesion of the eyelids. It is seen in all age groups. Chalazion is a non-inflammatory process and develops due to retained secretion of the meibomian or Zeis glands. Treatment of choice differs among clinicians and may include...

Full description

Saved in:
Bibliographic Details
Published inCurrent eye research Vol. 49; no. 2; p. 109
Main Authors Tashbayev, Behzod, Chen, Xiangjun, Utheim, Tor Paaske
Format Journal Article
LanguageEnglish
Published England 01.02.2024
Subjects
Chalazion - drug therapy
Chalazion - pathology
Eyelids - pathology
Eyelids - surgery
Glucocorticoids
Humans
Injections, Intralesional
Triamcinolone Acetonide - therapeutic use
Blepharitis
intralesional triamcinolone acetonide
incision and curettage
chalazion
Online AccessGet more information

Cover

More Information
Summary:A chalazion is one of the most common eye conditions presenting as a mass lesion of the eyelids. It is seen in all age groups. Chalazion is a non-inflammatory process and develops due to retained secretion of the meibomian or Zeis glands. Treatment of choice differs among clinicians and may include application of warm compress onto eyelids, lid hygiene, using local antibiotic ointment with or without steroids, injecting steroid solution (triamcinolone acetonide) into the lesion and surgical removal of the lesion by incision and curettage. In addition, there are some other experimented methods such as injection of botulinum toxin A, tarsal trephination, removal of chalazion by application of CO laser or cryogenic action. However, there is currently no commonly agreed treatment of choice. In this review, we aimed to summarize findings from clinical trials and hopefully, identify a treatment of choice in chalazion.
ISSN:1460-2202
DOI:10.1080/02713683.2023.2279014